These success, along with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assist the strategy of targeting ACKR3 as a unique technique to modulate the opioid procedure, which could open new therapeutic avenues for opioid-relevant Diseases. Along with the described above monomeric https://georgej798pgs4.livebloggs.com/profile